XVIVO Perfusion AB (0RKL)
Market Closed
15 Jun, 15:30
kr
271. 80
-2.4
-0.8753%
kr
12.08B Market Cap
384.18 P/E Ratio
- Div Yield
3,828 Volume
1.4 Eps
kr 274.2
Previous Close Want to track 0RKL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | 0.63 | 0.05 |
| | | - | - |
| | | - | - |
| | | - | 2.71 |
| | | - | 0.86 |
| | | - | 0.72 |
| | | - | 0.72 |
0RKL Earnings Reports FAQ
What is the earnings per share (EPS) for 0RKL?
The current EPS is 1.4.
What is the company's earnings growth rate?
Over the past 1 years, the earnings growth rate has been approximately -93.11%, reflecting the 0RKL's performance and LSE market conditions.
When is the next earnings release date?
XVIVO Perfusion AB has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for XVIVO Perfusion AB are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 0RKL at this time, as XVIVO Perfusion AB has no recent EPS data to calculate it.
